INTERNATIONAL PATENT: GUANGDONG DANXIA BIOPHARMACEUTICAL CO., LTD., 广东丹霞生物制药有限公司 FILES APPLICATION FOR "PREPARATION METHOD FOR HUMAN FIBRINOGEN AND PRODUCT"

GENEVA, Nov. 23 -- GUANGDONG DANXIA BIOPHARMACEUTICAL CO., LTD. (No. 216, Muxi Avenue, Muxi Industrial Park, Western SuburbShaoguan, Guangdong 512029), 广东丹霞生物制药有限公司 (中国广东省韶关市西郊沐溪工业园沐溪大道216号) filed a patent application (PCT/CN2025/092198) for "PREPARATION METHOD FOR HUMAN FIBRINOGEN, AND PRODUCT" on Apr 29, 2025. With publication no. WO/2025/237082, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC)...